St. Louis, MO, United States of America

Alejandro Perez-jones

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Monsanto Technology LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alejandro Perez-jones. Retrieved from https://idiyas.com/inventor/alejandro-perez-jones-z8codopm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alejandro Perez-Jones: Innovator in Crop Protection

Introduction

Alejandro Perez-Jones is a notable inventor based in Saint Louis, MO. He has made significant contributions to the field of agricultural science, particularly in crop protection. His innovative work focuses on reducing injury in crops through advanced chemical applications.

Latest Patents

Alejandro holds a patent titled "Early Applications of Encapsulated Acetamides for Reduced Injury in Crops." This patent represents his commitment to enhancing agricultural practices and improving crop resilience.

Career Highlights

He is currently employed at Monsanto Technology LLC, where he applies his expertise to develop solutions that benefit farmers and the agricultural industry. His work at Monsanto has positioned him as a key player in the field of agricultural innovation.

Collaborations

Due to space constraints, the details of his collaborations will not be included.

Conclusion

Alejandro Perez-Jones is a dedicated inventor whose work in crop protection exemplifies the importance of innovation in agriculture. His contributions continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…